SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-003648
Filing Date
2020-05-12
Accepted
2020-05-12 17:00:15
Documents
6
Period of Report
2020-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_051220.htm 6-K 12042
2 EXHIBIT 99.1 exh_991.htm EX-99.1 62391
3 EXHIBIT 99.2 exh_992.htm EX-99.2 72126
4 EXHIBIT 99.3 exh_993.htm EX-99.3 15121
5 EXHIBIT 99.4 exh_994.htm EX-99.4 11315
6 GRAPHIC logo.jpg GRAPHIC 6169
  Complete submission text file 0001171843-20-003648.txt   182588
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 20869889
SIC: 2834 Pharmaceutical Preparations